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Effects of iron supplementation and ET-18-OCH3 on
MDA-MB 231 breast carcinomas in nude mice
consuming a fish oil diet
WE Hardman, CJ Barnes, CW Knight and IL Cameron
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Summary Lipid peroxidation products can be cytotoxic. Our objectives were (1) to use two pro-oxidants (iron and a pro-oxidative drug) to
selectively increase lipid peroxidation in the implanted human breast tumours of mice consuming fish oil and (2) to kill the cancercells without
harming normal host tissues. The theoretical basis for selective cytotoxicity is that normal cells are better able to handle oxidative stress than
cancer cells. Male athymic nude mice, consuming an AIN-76 diet, were injected s.c. with MDA-MB 231 human breast carcinoma cells. Three
weeks later, all mice had palpable tumours, 3-10 mm in diameter, and diets were changed to modified AIN-76 diets containing 19%
menhaden fish oil and 1% corn oil with or without supplemental 0.3% ferric citrate. After 2 weeks, half of the mice on each diet (19% fish oil
with or without supplemental ferric citrate) were injected (three times per week for 2 weeks) with the ether-lipid drug edelfosine (ET-18-
OCH3). The concentration of lipid peroxidation products in tumours (as measured by thiobarbituric acid-reactive substances, TBARS) was
significantly increased by both ferric citrate and ET-18-OCH3. The TBARS in livers were not increased, nor was there evidence of other
harmful side-effects to the host mice. The addition of iron enhanced tumour cell death whereas ET-18-OCH3 suppressed tumour cell mitosis.
The use of iron supplementation combined with ET-18-OCH3 resulted in the slowest growth rate, lowest mitotic index, highest level of lipid
peroxidation products and increased the cytotoxic index in tumours without detectable harm to the host. That iron supplementation increased
tumour suppression beyond that expected from the increase in the concentration of TBARS in the tumour merits further investigation.
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Previous studies have revealed that a high level of fish oil in the
diet of nude mice can retard the growth or cause regression of
implanted human breast cancers (Borgeson et al, 1989; Gonzalez
et al, 1991; 1993). The addition of iron to the diet of mice
consuming fish oil further suppressed tumour growth (Gonzalez et
al, 1991). One proposed mechanism for the tumour regression
under these dietary conditions is that cancer cell death results from
an increase in the products of lipid peroxidation following
consumption of fish oil (Gonzalez et al, 1991). When fish oil is
consumed, the highly polyunsaturated fatty acids (HPUFAs) from
the fish oil are rapidly incorporated into the cellular membranes.
Lipid peroxidation products are formed when membrane poly-
unsaturated fatty acids (PUFAs) undergo oxidative damage; this
oxidative damage can be enhanced if iron is available to catalyse
the production of reactive oxygen species. Free radicals formed
during lipid peroxidation may physically damage cellular lipid
membranes, proteins and DNA (Masotti et al, 1988) and/or induce
cell death by apoptosis (McConkey and Orrenius, 1994) or other
forms of cell death. In addition, some of the products of lipid
peroxidation (e.g. malondialdehyde, 4-hydroxy-2-nonenal and 4-
hydroxy-2-hexenal) are directly toxic to the cells in relatively low
concentrations (Esterbauer et al, 1991). Increased lipid peroxida-
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tion has been thought to kill cancer cells preferentially because the
activities of cellular antioxidants that protect normal cells against
oxidative damage (i.e. catalase and glutathione peroxidase) may
be decreased in cancer cells (Corrocher et al, 1986). Thus cancer
cells are less able than normal cells to inactivate the oxygen
radicals formed as a consequence of lipid peroxidation and are
therefore less able to survive increased lipid peroxidation.
Results of previous studies using either cultured cells (exam-
ples: Begin et al, 1986; 1988; Canuto et al, 1991; Grammatikos et
al, 1994; Maehle et al, 1995; Padma and Das, 1996) or whole
animals (examples: Borgeson et al, 1989; Pritchard et al, 1989;
Gonzalez et al, 1991; 1993) have indicated that an increased expo-
sure to the types of HPUFAs found in fish oil, especially eicos-
apentanoic acid, kills a variety of cancer cells without killing
normal cells, and that addition of an iron-containing compound
may increase cell death. However, the question still remains as to
whether the most important cause of tumour regression and cell
death is: (1) induction of lipid peroxidation; (2) alteration of
eicosanoid production; (3) some other mechanisms associated
with the alteration in membrane fatty acids or (4) the addition of
iron to the diet or culture media.
We reasoned that if lipid peroxidative damage was the main
cause of tumour regression then systematically increasing lipid
peroxidation in tumours should increase tumour regression and
tumour cell death. To test this idea: (1) tumour-bearing nude mice
were fed a diet containing fish oil (which is rich in HPUFAs) to
provide the substrate for lipid peroxidation in the cancer cells; (2)
the fish oil diet was supplemented with a pro-oxidant, ferric
citrate, at0.3% (w/w) to enhance lipidperoxidation; (3) one halfof
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the mice consuming fish oil with supplemental ferric citrate and
one half of the mice consuming fish oil without supplemental
ferric citrate were treated with the ether-lipid drug edelfosine
(ET-18-OCH3). ET-18-OCH3 is readily incorporated into cellular
membranes and is hypothesized to kill cancer cells by inducing
lipid peroxidative damage to the plasma membrane (Wagner et al,
1992). In support ofthis mechanism of action for ET-18-OCH3, it
has been shown in cell culture studies that: (1) lipid peroxidation
was increased by addition of ET-18-OCH3 to cell cultures that
contained fish oil and ferric citrate and (2) cytotoxicity correlated
with the increase in lipid peroxidation when oxidative co-factors
(iron and ascorbic acid) were present (Wagner et al, 1992). Thus,
treatment of the host mouse with ET-18-OCH3 in addition to the
fish oil and ferric citrate in the diet was expected to increase lipid
peroxidation in the tumour.
Briefly, the results of this study indicate that lipid peroxidation
was significantly increased by supplementing a 19% fish oil diet
with ferric citrate and by periodic injections of ET-18-OCH3.
However, iron supplementation to a fish oil diet appears to make
an additional contribution to tumour suppression beyond that
attributed to the ability of iron to increase the concentration of
TBARS in the tumour. The mechanism by which iron supplemen-
tation makes this additional contribution to tumour growth
suppression has not been elucidated.
MATERIALS AND METHODS
Tumour cells
MDA-MB 231 human breast carcinoma cells (American Type
Culture Collection, Rockville, MD, USA) were cultured for injec-
tion into the tumour-bearing mice. The culture medium was an
enriched Ll5:SMEM base media supplemented with other factors
as described previously (Moyer and Aust, 1984).
Animals
Thirty-six male athymic nude mice (nu/nu, Harlan Sprague
Dawley, Madison, WI, USA), 6 weeks old, were used in this study.
The mice were housed under aseptic conditions (positive pressure,
designated nude mouse room, sterilized cages with microisolator
tops, sterile bedding and water) in atemperature- (24°C) and light-
controlled (12 h day-') room. All mouse handling was carried out
under a laminar flow hood. All animal use and handling was
approved by our Institutional Animal Care and Use Committee
before commencing the experiment. The animal care facilities are
accredited by the American Association for the Accreditation of
Laboratory Animal Care.
Experimental design
Cultured MDA-MB 231 cells were harvested, rinsed then
suspended in serum-free, L15:SMEM culture medium. Cells in
suspension were counted using a Coulter cell counter and the cell
count was adjusted to 20 x 106cells ml-'. The suspension was kept
well mixed during the time of injection. Cancer cells (106 cells in
0.05 ml of serum-free culture medium) were injected subcuta-
neously (s.c.) over each scapula on the upper back of the nude
mice. The MDA-MB 231 human breast carcinoma forms tumours
after s.c. injection into male nude mice and does not require
supplemented hormones for growth. Male mice were used to
prevent possible cyclic hormonal influences on tumour growth.
Palpable, measurable tumours were found beginning 10 days after
the cells were implanted and by 3 weeks the tumours had grown at
99% of the injection sites. The lengths and widths of palpable
tumours were measured three times weekly with Vernier calipers
during the entire experiment to establish growth curves of each
tumour before and after the dietary and ET-18-OCH3 treatments.
All mice were weighed weekly.
Mice were fed a standard AIN-76 purified diet (Table 1) from
receipt until 3 weeks after transplantation of the human breast
carcinoma cells. This allowed the carcinoma cells to become estab-
lished as growing tumours in the host mice before the onset ofthe
experimental dietary treatments. The cancer-bearing mice were
then divided into two groups (18 mice each). All mice had free
access to a modified AIN-76 purified diet (Table 1), which
contained 19% fish oil. The mineral mix incorporated into the basal
diet contained 0.6% ferric citrate (16-17% Fe), thus the basal diet
contained 0.02 g ferric citrate 100 g-' dry weight of food.
Supplemental ferric citrate was added to the diet ofone group of 18
mice atarateof0.3 g 100 g-' dry weightoffood. On acaloric basis,
the diets were balanced to the standard AIN-76 diet for protein,
minerals, vitamins and fibre; the adjustment for the calories in the
19% fish oil diets was made by subtracting sucrose calories. One
per cent com oil was included in the fish oil diets to provide suffi-
cient essential linoleic acid for mouse and tumour growth.
The diets were prepared weekly, individual daily portions for
each cage were packaged and the packages were stored in sealed
containers at -20°C to suppress spontaneous lipid peroxidation.
Table 1 Composition of the diet by weight per cent (g per 100 g of food)
Ingredient 5% Corn oil 19% Menhaden oiVl% corn oil
Corn oil 5.0 1.0
Menhaden oil - 19.0
Sugar 50.0 27.9
Casein 20.0 23.2
Cornstarch 15.0 17.4
AIN-76 vitamin mixa 1.0 1.15
AIN-76 mineralmixa 3.5 4.06
Choline bitartrate 0.2 0.23
DL-methionine 0.3 0.35
Cellulose 5.0 5.8
Total 100.0 100.1
Composition of the diets
by % caloriesb
Protein 20.7 20.6
Carbohydratec 67.5 40.1
Fat 11.6 39.3
Energy content of each diet
kcal g-1 3.85 4.52
aa-Tocopherol is 0.02 g 100g-' andfernc citrate (16-17% Fe3+) is 0.02 g 100g-'
ofthe basal diet. bCalonc content is calculated at 4 kcal g-' for protein and
carbohydrate and 9 kcal g-1 forfat. The diet that included a pro-oxidant (iron)
had 0.3 g 100 g-1 offemc citrate (16-17% Fe3+) added to the 19% Menhaden oil
diet. cThe percentage of calores from carbohydrate include the calones from
sucrose, comstarch and sucrose in the vitamin and mineral mix. Diet
components and chemicals: purified high-nitrogen casein, pure corn starch,
Alphacel (non-nutritive bulk cellulose) AIN-76 vitamin mixture, AIN-76 mineral
mixture and choline bitartrate (99% pure) was obtained from ICN Nutritional
Biochemicals, Cleveland, OH, USA. Imperal brand (Sugarland, TX, USA) extra-
fine pure cane sugar and 100% pure com oil (Wesson) was purchased locally.
DL methionine (cell culture, MW 149.2), menhaden fish oil and femc citrate was
purchased from Sigma, St Louis, MO, USA.
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The food was replaced every day and the weight offood consumed
per cage perday was recorded. Gonzalez et al (1992) reported that
there was not a significant increase in peroxidation products in
19% fish oil diets when food was stored at -20°C; however, there
was significant peroxidation after 24 h at room temperature. As the
diets were not sterilized, antibiotics (bacitracin, streptomycin and
neomycin, at 1 g each per 1) were added to the drinking water to
prevent infection.
The mice were maintained on the fish oil diets for 2 weeks to
allow HPUFA substitution of the membrane fatty acids before
beginning treatment with ET-18-OCH3 (edelfosine, Medmark
Pharma). ET-18-OCH3 was selected to further increase lipid
peroxidation based on the conclusion that the mechanism ofaction
ofET-18-OCH3 was through induction oflipid peroxidation at the
cellular membranes (Wagner etal, 1992). A non-lethal dose ofET-
18-OCH3, as reported in a previous study (Leder et al, 1987), was
selected. Half of the mice in each dietary group received ET-18-
OCH3, at a dose of 10 mg drug kg-' body weight injected s.c. on
the left rear flank three times per week for 2 weeks. The mice
received either 0.1 ml ofthe drug solution (30 mg ofthe drug was
dissolved in 10 ml ofsterile 0.9% Sodiumchloride) or ofthe saline
(controls) for each 30 g body weight.
Tissue collection and preparation
The experiment was terminated 2 weeks after the initiation of ET-
18-OCH3. The mice were anaesthetized using a ketamine/S.A.
rompun mixture (0.2 ml 25 g-' weight, i.m.) prepared by our
Laboratory Animal Resources veterinarian, then terminated by
cervical dislocation. Immediately after cervical dislocation, a
bloodsample (about 0.5-1 ml) for serumanalyses was obtainedby
Figure Photomicrograph of a 4 -im-thick section of a human MDA-MB 231
breast carcinoma grown in a nude mouse. Examples of a dying cell
(arrowhead) and of a cell in mitosis (arrow) are indicated
(haemotoxylin-eosin-stained, magnification, xl_ 00)
cardiac puncture. Subcutaneously growing primary human breast
carcinomas were excised, weighed, the dimensions measured and
their volumes calculated by using the formula for the volume of a
prolate spheroid (V = t/6 x length x width x depth). Terminal
volume ofthe excised tumours correlated significantly (P <0.001)
with the terminal volume of tumours measured in the live mice.
This indicated that the in situ tumour volume as estimated in live
mice was reliable. The lungs, liver and spleen were removed then
inspected for tumours and gross pathology. Each specimen of
primary cancer or host organ was rinsed with ice-cold 0.9%
sodium chloride, the excess saline was blotted and the specimen
was weighed. A piece ofeach specimen was fixed in 10% neutral
buffered formalin for 2 h then transferred to 70% ethanol for later
processing to histological slides. The remainder of each cancer
or organ was placed in 0.9% sodium chloride, flash frozen in
liquid nitrogen and stored at -90°C until further assays could be
performed.
Tissue analyses
At a laterdate, frozen tumours and normal organs were thawed and
homogenized individually at 4°C using a Polytron homogenizer.
An aliquot of the whole specimen homogenate was reserved for
analysis of total protein content. The total protein content of the
tissue homogenate of the tumour and of the host liver was
measured by the method of Bradford (1976) using the Bio-Rad
protein assay (micro-method).
The remainder of the homogenate was used in the TBARS
assays to estimate lipid peroxidation. Malondialdehyde and other
products oflipid peroxidation can be estimated spectrophotometri-
cally at 535 nm after reaction with thiobarbituric acid to obtain an
index for lipid peroxidation (Esterbauer et al, 1991). We realize
that TBARS do not measure all products oflipid peroxidation and
that there may be minor interference by other substances (sugars,
amino acids, etc.); however, this simple inexpensive test does
provide a good estimate ofchanges in overall lipid peroxidation of
tissues. The absorbance values obtained were compared with a
standard curve of known concentrations of malondialdehyde and
normalized by protein content of the specimen. The results are
reported as nmol ofTBARS per mg ofprotein.
The cytotoxic and mitotic indices were obtained from coded
haematoxylin-eosin-stained histological sections of the tumour
(see Figure 1). All scoring of the coded sections was done by one
individual, CWK, without knowledge ofthe treatment given to the
mouse. Cell death was determined by morphological indicators
of either apoptosis (marginalization of chromatin to the nuclear
envelope, nuclear fragmentation, cytoplasmic shrinkage) or
necrosis (pyknotic nucleus, eosinophilic cytoplasm, no cell
shrinkage). Mitosis was determined by the presence of mitotic
figures. At least 1000 contiguous cells in non-necrotic sections of
each tumour were counted. The cytotoxic and the mitotic indices
were expressed as thepercentage ofcells that were undergoing cell
death or that were in mitosis respectively.
Sizes of the axillary lymph nodes were recorded when enlarge-
ment was detected by palpation. At necropsy, metastatic tumours
were found in the axillary lymph nodes of almost all of the mice.
These were excised and the tumour cells were identified by
histology to be ofepithelial origin; however, no further testing has
been completed. The lymph node data were not adequate to
generategrowth curves oflymph node tumours because ofthe large
variation in the ratio ofhost-tumour tissue in the lymph node.
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Table 2 Caloric consumption, terminal body weights and terminal liver or spleen weights of groups of mice that consumed different dietary modifications for
4 weeks. Half of the mice on each diet received ET-18-OCH3 for 2 weeks before killing (n = 8-10 mice per group)
Diet With (+) or without (-) Calories Body weight Liver Spleen
ET-18-0CH3 (kcal per mouse day-1) (g per mouse ± s.e.) (g per mouse + s.e.) (g per mouse ± s.e.)
19% Fish oil - 21.35 ± 1.14 33.3 ± 1.48 1.70 ± 0.13 0.20± 0.01
19% Fish oil + 21.24 ± 1.07 38.7 ± 0.69 1.86 ± 0.09 0.22 ± 0.01
19% Fish oil + ferric citrate - 18.66 ± 0.93 37.0 ± 1.64 1.80 ± 0.04 0.23 ± 0.02
19% Fish oil + ferric citrate + 17.66 ± 1.23 35.3 ± 0.92 1.66 ± 0.08 0.21 ± 0.01
ANOVA showed that there were no significant differences in the mean caloric consumption, mean body, liver or spleen weights of the groups of mice with
different dietary modifications or ET-18-OCH3.
Table 3 Mean thiobarbituric acid reactive substances (TBARS in nmol TBARS mg-1 protein ± s.e.) in the liver or in the human
breast carcinoma of groups of mice consuming different dietary modifications with and without ET-18-OCH3 treatment injected
s.c. at 10 mg kg-1 body weight three times per week for 2 weeks before killing (n = number of mice)
Diet No ET-18-OCH3 n With ET-18-OCH3 n Row means
TBARS in livere
19% Fish oil 0.25 ± 0.056 7 0.30 ± 0.054 7 0.28 ± 0.038
19% Fish oil + ferric citrate 0.17 ± 0.061 5 0.34 ± 0.050 6 0.26 ± 0.045
Column means 0.21 ± 0.042 0.32 ± 0.036
TBARS in tumouiPzc
19% Fish oil 0.11 ± 0.050 5 0.81 ± 0.176 9 0.56 ± 0.144
19% Fish oil + ferric citrate 0.54 ± 0.243 3 1.15 ± 0.233c 7 0.96 ± 0.183
Column means 0.27 ± 0.131 0.96 ± 0.133
aTwo-way ANOVA of TBARS in the host liver showed that there was no significant difference due to the ET-18-OCH3 (column
means, P< 0.08) or due to the diet (row means, P = 0.87). There were no significant interactions between the diet and the ET-
18-OCH3. bTwo-way ANOVA of TBARS in the implanted human breast carcinoma showed that there was a significant increase
because of the ET-18-OCH3 (column means, P < 0.004) and due to ferric citrate (row means, P= 0.05). There were no
significant interactions between the diet and the ET-18-OCH3. cOne-way ANOVA showed that the content of TBARS in the
tumours of the group of mice that consumed supplemental ferric citrate and received ET-18-OCH3 was significantly greater than
that in the tumours of the group that consumed the fish oil diet.
Diagnostic serum enzyme levels were evaluated to determine
whether or not there were side-effects (damage to other tissues of
the host mouse) because of consumption of any of the diets. The
enzymes analysed were (an elevation ofa specific enzyme activity
indicates damage to the tissues listed in parenthesis; Davidson and
Henry, 1974): alkaline phosphatase (bone, liver); serum glutamic
oxaloacetic transaminase (heart, liver, skeletal muscle, kidney);
serum glutamic pyruvic transaminase (liver); lactic dehydrogenase
(increased with a variety of tissue damage but especially liver
damage); amylase (pancreas); creatine phosphokinase (thyroid,
brain, lung, heart). These analyses are routine clinical chemistry
analyses and were performed by the Clinical Pathology
Laboratory at University Hospital (San Antonio, TX, USA).
Appropriate controls were used for all tests to establish the
linearity of the procedures. The laboratory is certified by the
College ofAmerican Pathologists.
Statistical analyses
All samples were coded before analyses to minimize bias. SAS
statistical software was used for statistical analyses. Tests for
normality were performed on each data set. Two-way analysis
of variance (ANOVA) followed by one-way ANOVA and
Student-Newman-Keuls multiple range tests were used to deter-
mine if there were statistically significant (P < 0.05) differences
between the groups because of the ferric citrate, the ET-18-OCH3
or interactions between the ferric citrate diet and ET-18-OCH3.
Linear regression analysis was used to determine ifthe increase
in the mean tumour volume over the time of the experiment
showed a significant linear fit. Slope analysis for differences
between the regression of mean tumour volume per group was
performed by SAS using the general linear model procedure to
generate an ANOVA followed by a T-test between each pair of
lines against the null hypothesis that there was no difference
between the slopes. A P-value < 0.05 was used to indicate that
there was a significant difference between slopes ofthe regression
lines, and thus that the tumour growth rates represented by the
slopes were significantly different.
RESULTS
Dietary modifications and ET-18-OCH3on the
tumour-bearing host mouse
ANOVA showed that there were no significant differences
between experimental groups of mice in: (1) body weight (Table
2); (2) daily caloric consumption (Table 2) or (3) the weights
of liver or spleen (Table 2). Routine clinical chemistry analyses
were performed on individual mouse serums for the amount of
the enzymes; alkaline phosphatase, serum glutamic oxaloacetic
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transaminase, serum glutamic pyruvic transaminase, lactic dehy-
Regression analyses of tumour growth drogenase, amylase, creatine phosphokinase. ANOVA showed no
significant differences between groups in the amounts of any of
the six serum enzymes (data not shown). There were no apparent
/* differences between groups in the gross pathology or histology of
the liver, lung or spleen. Taken together, these results indicate that
neither the supplementation with ferric citrate nor ET-18-OCH3
>>0: 0 2 treatment had a detectable or significant damaging effect on the
l ~ -> o _ liver, bone, spleen, heart or pancreas or in any noticeable way
altered the tissues or the overall health status of the mice.
AA A^ _ { * ° * 3 Likewise, analyses of the concentration of TBARSs (an indica-
A =;3 4 tion of lipid peroxidation) in the liver of the host mice (Table 3)
I,1 ._,, . ,,.,., lIIIIII showed no significant main effects because of either the dietary
0 5 10 15 20 25 30 35 modification or ET-18-OCH treatment.
3
Days after beginning of dietary intervention Supplementation ofthe 19% fish oil diet with 0.3% ferric citrate
did not significantly increase the serum iron level above that ofthe
irowth rate of MDA-MB231 human breast carcinoma in nude mice. mice given 0.02% ferric citrate in their food. The mean serum iron
umours were divided into groups and fed modified AIN-76 diets level of the group of mice fed 19% fish oil with 0.02% dietary 19% fish oil with and withoutferric citrate. After 2 weeks on the
half ofthe mice on each diet were injected with ET-18-OCH ferric citrate was 161.6 ± 8.8 mg dl-1 (mean ± s.e.); the mean serum
per week for 2 weeks. The diets and treatments were: 1, fish oil; iron level ofthe group ofmice fed 19% fish oil with supplemental
rith ET-18-OCH3; 3, fish oil with ferric citrate; 4, fish oil, ferric citrate
*OCH3. See Table 4 forthe summary of statistical analyses of 0.3% ferric citrate was 173.0 ± 10.9 mg d11. ANOVA revealed that
these serum iron levels were not significantly different.
Table 4 Mean growth rates of the implanted MDA-MB 231 human breast carcinomas of groups of mice that consumed different diets for 4 weeks. Half of the
mice on each diet group received ET-18-OCH3 for 2 weeks before killing (n =8-10 mice per group)
Group Dieta With (+) or without (-) Growth rateb Correlation to linear Growth rate is significantly
ET-18-OCH3 (mm3 day-' ± s.e.) regressionc (,) differentd from all groups except
1 19% Fish oil - 9.64 ± 1.2 0.97
2 19% Fish oil + 3.97 ± 0.5 0.95
3 19% Fish oil + ferric citrate - 0.43 ± 0.4 0.20 4
4 19% Fish oil + ferric citrate + 0.35 ± 0.3 0.30 3
aThe composition of the diets is listed in Table 1. bSlope of the best fit linear regression line ± s.e. of that slope. cThe slope of the line of groups 1 and 2 shows a
significant (P < 0.05), positive linear fit by linear regression analysis. The slope of the line of groups 3 and 4 is not significantly different from 0. rThe growth
rates (slopes) were compared by SAS using a general linear model to generate an analyses of variance followed by a T-test against the null hypothesis that
there was no difference between the slopes of each pair of lines. P < 0.05 was used to indicate significant differences.
Table 5 Mitotic and cytotoxic indices (± s.e.) in the implanted MDA-MB 231 tumours from groups of mice that consumed different dietary
modifications for 4 weeks either without or with ET-18-OCH3 treatment for 2 weeks before killing (n = number of mice scored for each mean)
Diet No ET-18-OCH3 With ET-18-OCH3
mean + s.e. (n) mean + s.e. (n) Row means
Mitotic index (%)
19% Fish oil 2.17 ± 0.69 (3) 1.16 ± 0.09 (9) 1.41 ± 0.21
19% Fish oil + ferric citrate 1.72 ± 0.54 (5) 1.15 ± 0.05 (9) 1.36 ± 0.16
Column means 1.90a ± 0.34 1.16 ± 0.05
Cytotoxic index (%)
19% Fish oil 3.86 ± 0.91 (3) 5.84 ± 0.81 (9) 5.34 ± 0.68
19% Fish oil + ferric citrate 9.85 ± 2.74 (5) 7.19 ± 1.29 (9) 8.14 ± 1.14b
Column means 7.6 ± 1.71 6.5 ± 0.76
aTwo-way ANOVA revaled a significant difference in the mitotic index in the tumour because of the ET-18-OCH3 treatment (column means,
P = 0.006). there was no significant difference in the mitotic index as a result of the diets (row means, P = 0.80). bTwo-way ANOVA revealed a
marginally significant increase in the cytotoxic index in the tumour as a result of the consumption of ferric citrate (row means, P= 0.053). There
was no significant difference in the cytotoxic index due to the ET-18-OCH3 treatment (column means, P= 0.62).
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Dietary modification and ET-18-OCH3 on the implanted
human breast carcinoma
Two-way ANOVA (Table 3) of the concentration of TBARSs in
the implanted human breast carcinoma revealed that there was a
significant increase in TBARS because ofthe ferric citrate supple-
mentation (P = 0.05) and ET-18-OCH3 (P < 0.004).
The mean tumour volume of each group was normalized to a
volume of0 at the beginning ofthe fish oil diets. This was accom-
plished by subtracting the mean tumour volume at the beginning
of the fish oil from the tumour volume at that time and at each
subsequent measurement. The normalized mean daily tumour
volume for each dietary group plotted as a function ofthe number
ofdays after initiation ofthe fish oil diet is presented in Figure 2.
Least-squares linearregression analyses oftumour volume vs time
showed that the tumour growth rate was significantly less because
of addition of ferric citrate or because of treatment with ET-18-
OCH3 (summarized in Table 4). Figure 2 illustrates that there was
not a significant increase in the mean tumour volume ofmice that
consumed high fish oil plus ferric citrate (with or without ET-18-
OCH3), thus the mean tumour growth ofthese two groups was nil.
The mitotic and cytotoxic indices (per cent ofcells in mitosis or
per cent ofdying cells respectively) were determined from 4-gm-
thick histological sections of non-necrotic areas of the tumour.
Two-way ANOVA of the mitotic index (Table 5, row means)
revealed that the ferric citrate supplementation to the diet of the
mice did not significantly alter the mitotic index in the tumours.
However, ET-18-OCH3 treatment did significantly (P < 0.05)
decrease the mitotic index (Table 5, column means) in the tumours
of mice that received the ET-18-OCH3 compared with the mice
that did not receive ET-18-OCH3.
Two-way ANOVA ofthe cytotoxic index indicated that there was
a marginally significant increase (P = 0.053) in the percentage of
dying cells because of ferric citrate supplementation. Specifically,
20
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Figure 3 The linear regression analyses (± 95% confidence interval) of
concentration of lipid peroxidation products (thiobarbituric acid-reactive
substances, TBARS) in MDA-MB 231 human breast carcinomas grown in
nude mice against the mean tumour growth rate (mm3 day-'). Diets and
treatments are indicated. Error bars indicate s.e.m. for the growth rate of the
group (see Table 4 for data), n = 8-10 mice per group. Dashed lines indicate
the 95% confidence interval for the regression line with the fish oil plus
supplemental ferric citrate group excluded from the regression analyses
as it is outside the 95% confidence interval. The slope of the regression
line = -8.80, Pfor slope = 0.05
the results of one-way ANOVA demonstrated that consumption of
the diet containing high fish oil plus ferric citrate significantly
increased the cytotoxic index in the tumour (row means). There was
not a significant difference in the cytotoxic index because ofthe ET-
18-OCH3 treatment (column means).
When interpreting the mitotic, cytotoxic and TBARS values, it
should be noted that some tumours regressed because of the diet
and/or ET-18-OCH3 treatment and were either undetectable or too
small to analyse at the time of necropsy. Thus, for these tumours,
there was insufflcient or no tumour remaining to analyse for
mitotic index, for cytotoxic index orfor TBARS content. The lack
ofmeasured values on tumours thatregressedto the greatest extent
influences the ability to detect statistically significant changes in
mitotic index, cytotoxic index or TBARS because of the diet
and/or the ET-18-OCH3.
DISCUSSION
The main purpose ofthis study was to evaluate whether increasing
lipid peroxidation, as measured by TBARS, in the tumour would
correlate with decreased growth rates in implanted human breast
carcinomas and to determine if there was detectable harm to the
tumour-bearing host mice.
Comparisons with similar past research
The research results in this report are in general agreement with
other published findings and we add several new findings. Our
results confirm those of earlier reports (Gonzalez et al, 1991,
1993) that supplementation of the high fish oil diet with a pro-
oxidant, ferric citrate, suppresses breast cancer growth and
increases lipid peroxidation products in human breast cancer
growing in nude mice. Our original findings are as follows.
1. The significant accumulation oflipid peroxidation products in
the breast cancer cells was not accompanied by a significant
increase in lipid peroxidation products in the host liver. This
indicates that there was selectivity ofthe intervention between
the cancer cells and a representative normal host cell popula-
tion.
2. Addition ofthe ether-lipid drug ET-18-OCH3 increased lipid
peroxidation in the tumour and the increased lipid peroxida-
tion generally correlated with a decreased tumour growth rate.
However, dietary supplementation with iron in the form of
ferric citrate caused a greater suppression in the growth rate
than would be expected from the measured increase in lipid
peroxidation.
3. Addition ofiron to the fish oil diet caused a significant
increase in the cytotoxic index (cell death) ofthe tumour
without a decrease in the mitotic index (rate ofcell division),
whereas the addition ofET-18-OCH3 to the fish oil diet
caused a significant decrease in the mitotic index ofthe
tumour without a significant increase in the cytotoxic index.
It therefore seems that iron supplementation and ET-18-OCH3
suppress tumour growth via different mechanisms. The exact
mechanisms involved remain to be elucidated.
Assessment of the dietary modifications and
ET-18-OCH3 on the host
It was thought important to look for harmful side-effects of the
treatments on the host, as detrimental side-effects would influence
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the applicability ofthe same or a similar treatment to humans with
cancer. The diagnostic serum enzymes tested are commonly used
clinically to indicate organ damage or disease. In addition, histo-
logical sections of the liver, lungs and spleen were examined for
histological evidence ofdamage to these organs. At the dosages of
ET-18-OCH3 or of fish oil plus ferric citrate used in this study,
neither serum enzyme levels nor microscopic examination of the
histological sections ofliver, lungs orspleen indicateddamage that
could be attributed to the dietary modifications or to the ET-18-
OCH3. All mice appeared healthy and active, had similar food
intake and had similar weight gains during the experiment. Thus,
there were no detectable harmful side-effects on the host mouse
because of the dietary modifications or because of the ET-18-
OCH3 treatment. Additionally, as there were no significant differ-
ences between groups in food consumption or weight gains, food
restriction cannot account for suppression oftumour growth.
Possible mechanisms of action leading to tumour
regression
The gross measurements and themicroscopic examination ofhisto-
logical sections of tumours revealed that there was an increase in
tumour cell death because ofconsumption ofthe fish oil and ferric
citrate. The result was that the mean tumourgrowth rate was almost
nil in the mice that consumed 19% fish oil plus ferric citrate either
with or without ET-18-OCH3. What mechanisms related to fatty
acid and iron consumption would explain tumour regression?
Role ofalteration in eicosanoidproduction
Eicosanoids are important regulators of cell proliferation and of
the immune response. It has been shown that n-3 fatty acids
suppress the synthesis of eicosanoids in the tumour (Rose et al,
1995). However, no measures of eicosanoids were made in this
study so we have no evidence for further comment.
Role oflipidperoxidation
Both cancer cells and normal cells will incorporate HPUFAs in the
cellular membranes when exogenous HPUFAs are supplied in the
diet. The HPUFAs in cellular membranes readily undergo sponta-
neous lipid peroxidation and free radicals are formed. The free
radicals can react with other HPUFA chains in cellular membranes
resulting in a cascade oflipid peroxidation and free radical forma-
tion. If the process is not halted, lipid peroxidation products can
reach cytotoxic levels. However, normal cells do not accumulate
lipid peroxidation products to the same extent as do cancer cells.
This difference between normal cells and cancer cells in the accu-
mulation of lipid peroxidation products is attributed to: compart-
mentalization and protection from oxygen free radicals; the
presence of effective cellular antioxidants; and the effective
removal and neutralization of peroxidized lipids by the normal
cells (Horrobin, 1994). In support of the role of increased lipid
peroxidation, it has been reported that there is less regression of
tumours when lipid peroxidation was suppressed by addition of
antioxidants to a diet containing fish oil and ferric citrate
(Gonzalez et al, 1991). It is therefore hypothesized that these
fundamental differences in the ability to handle oxidative stress
between normal and cancer cells can be exploited to selectively
kill the cancer cells with little or no harm to the normal cells.
Role ofiron
The graphic presentation of data in Figure 3 shows that increased
lipid peroxidation (as measured by TBARSs) is generally negatively
correlated with tumour growth. However, the data presented in
Figure 3 make clear that tumour growth is not solely dependent on
the accumulation oflipid peroxidation products as measured by the
concentration of TBARS. The tumour growth rate in the group of
mice that consumed fish oil and ferric citrate is suppressed much
more than would be expected from the increase in TBARS and in
fact is outside the 95% confidence interval for the regression of
TBARS against growth rate for the other three groups. This indi-
cates thataddition ofdietary iron, inthe form offerric citrate, makes
an additional contribution to suppression ofthe tumour growth rate.
Apparently, the mechanism by which iron works to cause tumour
regression is inaddition toiron's ability toenhance thegeneration of
lipid peroxidation products (as measured by TBARS). It is impor-
tant to recognize that, in addition to malondialdehyde, 4-hydroxy-
nonenal and 4-hydroxyhexenal may also be formed during lipid
peroxidation and the formation ofthese two alkenals might also be
enhanced in the presence ofiron. These alkenals are detected by the
TBARS reaction; however, they may be present and are cytotoxic
at micromolar concentrations (Esterbauer et al, 1991) and would
constitute but a small fraction of the TBARS. An increase in the
localized concentration ofthese alkenals could in this way increase
cell death without a measurable increase in the TBARS level.
The suggestion of another mechanism of how iron worked to
make an additional contribution to suppression of carcinoma
growth stems from the fact that iron supplementation enhanced the
cytotoxic index without lowering the mitotic index. The increased
cell death could be because of iron enhanced free radical damage
to proteins or to DNA, which would not be measured by TBARS.
Yet another possible mechanism for the effect ofiron on tumour
cell death could be an increased uptake ofiron into the cancer cells.
Breast cancer cells often have higher numbers oftransferrin recep-
tors than normal breast epithelial cells (Inoue et al, 1993). Thus, the
cancer cells may have sequestered a higher level ofiron, resulting
in increased damage from the iron even though the mean serum
iron was not significantly increased in the group that received
supplemental iron. Future research is needed to: elucidate the
mechanism(s) by which iron supplementation, in this system, selec-
tively facilitated cancer cell death without suppression of mitotic
activity; determine if other types, amounts and preparations of
PUFA will be as effective as Menhaden fish oil in tumour suppres-
sion; and determine any long-term side-effects of the therapeutic
approach. The marked tumour suppressive results obtained in this
study clearly warrant further research on this novel and effective
approach to breast cancer therapy. The results of this research
suggest that a cancer therapy protocol incorporating omega-3 fatty
acids and iron might be an effective cancer therapy for humans.
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